关注
Jia Li
Jia Li
在 mskcc.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
SM Stein, ES James, Y Deng, X Cong, JS Kortmansky, J Li, C Staugaard, ...
British journal of cancer 114 (7), 737-743, 2016
2072016
Conditional deletion of the colony stimulating factor‐1 receptor (c‐fms proto‐oncogene) in mice
J Li, K Chen, L Zhu, JW Pollard
Genesis 44 (7), 328-335, 2006
1442006
Era of universal testing of microsatellite instability in colorectal cancer
X Zhang, J Li
World journal of gastrointestinal oncology 5 (2), 12, 2013
1042013
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
DC Glassman, RL Palmaira, CM Covington, AM Desai, GY Ku, J Li, ...
BMC cancer 18 (1), 1-10, 2018
922018
First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer
MW Saif, J Li, L Lamb, K Kaley, K Elligers, Z Jiang, S Bussom, SH Liu, ...
Cancer chemotherapy and pharmacology 73, 373-380, 2014
842014
Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer
VM Neumeister, CA Sullivan, R Lindner, K Lezon-Geyda, J Li, J Zavada, ...
Breast cancer research and treatment 136, 67-75, 2012
612012
First-line treatment of metastatic pancreatic adenocarcinoma: can we do better?
MY Merl, O Abdelghany, J Li, MW Saif
JOP. Journal of the Pancreas 11 (4), 317-320, 2010
372010
Any progress in the management of advanced pancreatic cancer
J Li, MW Saif
Jop 10 (4), 361-365, 2009
312009
Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going?
J Li, MY Merl, J Chabot, MW Saif
JOP. Journal of the Pancreas 11 (4), 310-312, 2010
282010
Advancements in the management of pancreatic cancer
J Li, MW Saif
JOP 10 (2), 109-117, 2009
262009
The first-line treatment for advanced pancreatic cancer
MY Merl, J Li, MW Saif
JOP. Journal of the Pancreas 11 (2), 148-150, 2010
222010
Wave propagating in multilayers composed of piezo electric and piezo magnetic layers
TT Nguyen, R Abdelmoula, J Li, Y Roussigne, A Stashkevich
Composites Part B: Engineering 93, 289-301, 2016
202016
Any Second-Line Therapy for Advanced Pancreatic Cancer? Highlights from the'2010 ASCO Gastrointestinal Cancers Symposium'. Orlando, FL, USA. January 22-24, 2010
J Li, MY Merl, MW Saif
JOP. Journal of the Pancreas 11 (2), 151-153, 2010
202010
Locally advanced pancreatic adenocarcinoma: Are we making progress?
J Li, J Ng, J Allendorf, MW Saif
JOP. Journal of the Pancreas 12 (4), 347-350, 2011
162011
Safety and efficacy of single-day GemOx regimen in patients with pancreatobiliary cancer: a single institution experience: Presented as a Poster (Abstract# 214) at the 2010 …
J Li, M Merl, MX Lee, K Kaley, MW Saif
Expert Opinion on Drug Safety 9 (2), 207-213, 2010
162010
Staphylococcus aureus bacteremia related with erlotinib skin toxicity in a patient with pancreatic cancer.
J Li, J Peccerillo, K Kaley, MW Saif
JOP: Journal of the Pancreas 10 (3), 338-340, 2009
162009
Homologous recombination deficiency (HRD): A biomarker for first-line (1L) platinum in advanced pancreatic ductal adenocarcinoma (PDAC).
W Park, W Wong, KH Yu, AM Varghese, N Riaz, VP Balachandran, ...
Journal of Clinical Oncology 37 (15_suppl), 4132-4132, 2019
142019
Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
J Li, MW Saif
Biologics: Targets and Therapy, 429-441, 2009
122009
Phase II study of modified FOLFOX6 with bevacizumab in metastatic gastroesophageal adenocarcinoma
J Li, X Yao, JS Kortmansky, NA Fischbach, S Stein, Y Deng, Y Zhang, ...
American Journal of Clinical Oncology 40 (2), 146-151, 2017
112017
Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer
J Li, CJ Ko, MW Saif
Cutaneous and Ocular Toxicology 28 (3), 144-148, 2009
112009
系统目前无法执行此操作,请稍后再试。
文章 1–20